RxDoctor Payments Data

Sepehr Broukhim

Psychiatry · Sherman Oaks, CANPI 1174715965

Payments from drug & device makers

$6,768in general payments, 2019–2025

Across 261 payments — averaging $25.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$726
  • Lundbeck LLC$664
  • Supernus Pharmaceuticals, Inc.$506
  • Takeda Pharmaceuticals U.S.A., Inc.$497
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$489
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$6,768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,768 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate30$355
Lurasidone Hcl11$291
Lamotrigine27$191
Paroxetine Hcl12$138
Aripiprazole12$134
Gabapentin17$101
Citalopram HbrCitalopram Hydrobromide20$59
Fluoxetine Hcl19$57
Escitalopram Oxalate33$38
Alprazolam14$36
Diazepam12$31

Paid to pharmacies, not to this prescriber.

Other psychiatry in Sherman Oaks

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →